HealthDay News — Wireless peripheral nerve stimulation (PNS) is beneficial for chronic intractable pain secondary to postherpetic neuralgia, according to a case report published online in PAIN Practice.
Bart Billet, MD, from AZ Delta Hospital in Roeselare, Belgium, and colleagues examined the analgesic effects of a minimally invasive wireless neuromodulation in the treatment of chronic intractable pain secondary to postherpetic neuralgia in a 78-year-old male. He had compromised immune status and was deemed a suitable candidate for treatment. Two subcutaneous electrodes were placed at the level of T7-T8 under fluoroscopic guidance along the T7 intercostal nerve. The external transmitter, which was used to power the stimulator, was worn with a belt over a single layer of clothing. The procedure required only a small incision for electrode placement.
The researchers observed a reduction in pain score from 8 to 3, with a concomitant reduction in pain medication following an uneventful procedure. Before the trial, and at 1 and 3 months, the EuroQoL 5 dimensions questionnaire score was 0.102, and 0.630 and 0.576, respectively.
“Subcutaneous placement of electrodes with our minimally invasive technique and wireless neuromodulation technology was safe and effective,” the authors wrote.
Billet B, Wynendaele R, Vanguathem NE. A novel minimally invasive wireless technology for neuromodulation via percutaneous intercostal nerve stimulation (PNS) for post-herpetic neuralgia: A case report with short-term follow-up [published online June 20, 2017]. Pain Pract. doi:10.1111/papr.12607